期刊
NANOMEDICINE
卷 3, 期 3, 页码 343-355出版社
FUTURE MEDICINE LTD
DOI: 10.2217/17435889.3.3.343
关键词
DC targeting; nanoparticle; oral vaccination; PEG; PLGA; vaccine delivery
资金
- NIBIB NIH HHS [R56 EB000487, R01 EB000487, EB000487] Funding Source: Medline
Vaccines for many infectious diseases are poorly developed or simply unavailable. There are significant technological and practical design issues that contribute to this problem; thus, a solution to the vaccine problem will require a systematic approach to test the multiple variables that are required to address each of the design challenges. Nanoparticle technology is an attractive methodology for optimizing vaccine development because design variables can be tested individually or in combination. The biology of individual components that constitute an effective vaccine is often well understood and may be integrated into particle design, affording optimal immune responses to specific pathogens. Here, we review technological variables and design parameters associated with creating modular nanoparticle vaccine systems that can be used as vectors to protect against disease. Variables, such as the material and size of the core matrix, surface modification for attaching targeting ligands and routes of administration, are discussed. Optimization of these variables is important for the development of nanciparticle-based vaccine systems against infectious diseases and cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据